S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

NKTR Nektar Therapeutics

1.57

-0.10 (-5.99%)

May 03 2024 - Closed

Delayed by 15 minutes

Nektar Therapeutics shares rise on narrower Q1 loss

To read the full story on Seeking Alpha, click here.

Nektar Therapeutics (NASDAQ:NKTR)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Nektar Therapeutics Charts.

Nektar Therapeutics (NASDAQ:NKTR)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Nektar Therapeutics Charts.

Nektar Therapeutics News

Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets
Thursday 2 May 2024 (2 days ago) • PR Newswire (US)

Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
Friday 22 March 2024 (1 month ago) • PR Newswire (US)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata
Tuesday 5 March 2024 (2 months ago) • PR Newswire (US)

Form 8-K - Current report
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)

Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results
Monday 4 March 2024 (2 months ago) • PR Newswire (US)

Form 8-K - Current report
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)

Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX
Monday 4 March 2024 (2 months ago) • PR Newswire (US)

Nektar Management to Present at the TD Cowen 44th Annual Health Care Conference
Tuesday 27 February 2024 (2 months ago) • PR Newswire (US)

Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2023 on Monday, March 4, 2024, After Close of U.S.-Based Financial Markets
Monday 26 February 2024 (2 months ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 22 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 22 February 2024 (2 months ago) • Edgar (US Regulatory)

More Nektar Therapeutics News Articles

Alternet Systems (PK)

Marketing Worldwide (PK)

Bell Buckle (PK)

Umbra Applied Technologies (PK)

Yuenglings Ice Cream (PK)

Moon Equity (PK)

Ubiquitech Software (PK)

Auto Parts 4Less (PK)

AMC Entertainment

Astra Energy (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions